本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

44.43
-0.3100-0.69%
盤後44.820.3886+0.87%19:46 EDT
成交量:80.34萬
成交額:3,574.34萬
市值:41.32億
市盈率:-192.87
高:45.00
開:44.39
低:44.12
收:44.74
52周最高:48.61
52周最低:13.88
股本:9,299.29萬
流通股本:9,122.00萬
量比:0.53
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-0.2304
每股收益(LYR):-0.2864
淨資產收益率:-69.38%
總資產收益率:-6.46%
市淨率:41.85
市盈率(LYR):-155.16

資料載入中...

2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/07

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities